{"id":"NCT04004208","sponsor":"Bayer","briefTitle":"Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy","officialTitle":"Open-label, Randomized, Two-Arm, Controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal (IVT) Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity (ROP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-25","primaryCompletion":"2021-02-12","completion":"2021-02-12","firstPosted":"2019-07-01","resultsPosted":"2022-05-06","lastUpdate":"2022-05-06"},"enrollment":113,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Retinopathy of Prematurity (ROP)"],"interventions":[{"type":"DRUG","name":"Eylea (Aflibercept, BAY86-5321)","otherNames":[]},{"type":"PROCEDURE","name":"Laser photocoagulation","otherNames":[]}],"arms":[{"label":"Aflibercept arm","type":"EXPERIMENTAL"},{"label":"Laser photocoagulation arm","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate how well aflibercept works in babies with ROP, comparing it with laser therapy. The study also has the objective to demonstrate how safe aflibercept is when used in babies, and describe how the drug moves into, through and out of the body.","primaryOutcome":{"measure":"Proportion of Participants With Absence of Active ROP and Unfavorable Structural Outcomes","timeFrame":"At 24 weeks after starting study treatment","effectByArm":[{"arm":"Aflibercept 0.4 mg","deltaMin":0.855,"sd":null},{"arm":"Laser Photocoagulation","deltaMin":0.821,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":11},"locations":{"siteCount":90,"countries":["Argentina","Austria","Belgium","Brazil","Bulgaria","Czechia","Greece","Hong Kong","Hungary","Israel","Italy","Japan","Malaysia","Netherlands","Poland","Portugal","Romania","Russia","Singapore","Slovakia","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["38200320","35881122"],"seeAlso":["http://www.clinicaltrialsregister.eu/","http://clinicaltrials.bayer.com/"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":75},"commonTop":["Retinal haemorrhage","Conjunctivitis","Eyelid oedema","Conjunctival haemorrhage","Umbilical hernia"]}}